AGYTF Stock Price, Chart, Stats & News

Allergy Therapeutics plc
Save
Allergy Therapeutics plc (AGYTF) does not currently pay a dividend.
756.30M
Market cap
–
Current P/E
117.65x
Forward P/E
AGYTF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Allergy Therapeutics plc is a biotechnology firm dedicated to the research, development, and commercialization of innovative treatments for allergic conditions. The company offers a variety of allergen-specific immunotherapies, available as both injectable solutions and sublingual (under-the-tongue) formulations. Their product line includes prescription medications specifically designed to address pollen-related allergies, such as those caused by grasses, weeds, and trees, along with various diagnostic tools.
Similar securities
Based on sector and market capitalization
Report issue





